

| Particulars (in ₹ Cr.) | FY 2023 | FY 2022 |
|---|---|---|
| Total Revenue | 207.35 | 148.04 |
| Total Expenses | 163.05 | 132.95 |
| Profit Before Tax | 44.29 | 15.09 |
| Profit After Tax | 33.52 | 11.19 |
| Operating Profit After Depreciation | 45 | 16.23 |
| Particulars (in ₹ Cr.) | FY 2023 | FY 2022 |
|---|---|---|
| Fixed Assets | 59.74 | 28.59 |
| Total Non Current Assets | 73.55 | 40.02 |
| Total Current Assets | 77.48 | 21.53 |
| Total Assets | 151.03 | 61.54 |
| Total Shareholder's Fund | 125.80 | 36.52 |
| Particulars (in ₹ Cr.) | FY 2023 | FY 2022 |
|---|---|---|
| Net Cash From Operating Activities | 14.52 | 16.35 |
| Net Cash Used In Investing Activities | -33.10 | -18.49 |
| Net Cash Used In Financing Activities | 48 | -4.51 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 475.48 | 330.85 | 206.18 | 147.94 | 136.87 |
| Total Expenses | 353.41 | 236.93 | 161.65 | 132.77 | 122.69 |
| Profit Before Tax | 122.07 | 93.92 | 44.53 | 15.17 | 14.19 |
| Profit After Tax | 90.73 | 69.21 | 33.74 | 11.27 | 10.29 |
| Operating Profit After Depreciation | 122.57 | 94.33 | 45.23 | 16.31 | 15.49 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 154.90 | 66.85 | 59.74 | 28.35 | 22.67 |
| Total Non Current Assets | 176.15 | 76.55 | 73.55 | 39.51 | 23.06 |
| Total Current Assets | 152.16 | 143.98 | 77.48 | 22.04 | 26.09 |
| Total Assets | 328.31 | 220.53 | 151.03 | 61.55 | 49.15 |
| Total Shareholder's Fund | 273.02 | 192.25 | 125.80 | 36.56 | 23.95 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 68.63 | 36.69 | 17.17 | 17.48 | 17.53 |
| Net Cash Used In Investing Activities | -70.37 | -18.05 | -57.23 | -19.64 | -8.47 |
| Net Cash Used In Financing Activities | -0.69 | -3.44 | 48 | -4.51 | -1.53 |
No data available
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 189.85 | 174.29 | 139.02 | - | 114.09 |
| Total Expenses | 97.78 | 95.49 | 92.30 | - | 73.82 |
| Profit Before Tax | 78.76 | 68.56 | 36.88 | - | 35.40 |
| Profit After Tax | 58.79 | 51.31 | 27.35 | 9.85 | 26.60 |
| Operating Profit after Depreciation | 93.51 | 79.87 | 47.21 | - | 43.72 |
₹1.1/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
No data available
On 6 November 2025
04 Nov 2025, 10:39 am
24 Sep 2025, 03:26 pm
08 Sep 2025, 04:49 pm
On 29 September 2025
29 Aug 2025, 03:45 pm
On 27 August 2025
23 Aug 2025, 04:53 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.